Argentina and Colombia brace for a Covid-19 winter surge
Argentina and Colombia have seen a rise in Covid-19 cases and deaths, with the risk of transmission likely to increase as the winter season approaches.
Therapy Areas
HIV treatment: are long-acting therapies the future?
Long-acting dosing regimens can make HIV treatment more convenient and reduce the burden of living...
Tiziana and FHI Clinical work on Phase II intranasal Covid-19 drug trial
The trial will monitor the attenuation of pulmonary pathology in 80 participants enrolled at up...
ViiV Healthcare and Halozyme partner to develop long-acting HIV therapies
ViiV Healthcare and Halozyme plan to start experiments with ENHANZE by year-end for the drug...
EC buys 150 million additional doses of Moderna’s Covid-19 vaccine
Moderna will commence the delivery of the Covid-19 variant booster vaccine candidate next year.
Fujitsu to study Covid-19 treatments using supercomputer Fugaku
Fugaku will be used to discover small molecule inhibitory compounds and study molecular mechanism in hindering Covid-19.
Tonix to develop TNX-102 SL for long Covid treatment
In the third quarter of this year, Tonix will discuss Phase II trial design to assess the drug for long Covid with the US FDA.
EU gets partial win in AstraZeneca Covid-19 vaccine supply case
If AstraZeneca fails to supply in compliance with the court ruling, the company will have to pay $12 per dose in penalty.
Edesa Biotech to continue global Covid-19 drug trial
The DSMB recommended planned enrolment in the trial based on blinded comparative data from interim analysis.
Australia recommends AstraZeneca Covid-19 vaccine for people over 60
The AstraZeneca vaccine is now preferred in Australia for this age group due to an increased risk of TTS events in people aged 50 to 59 years.
Umoja Biopharma raises $210m to advance next-gen cancer immunotherapy technology
The company is building an integrated cellular immunotherapy platform to reprogramme immune cells in vivo.
